HAEM4:Gamma Heavy Chain Disease: Difference between revisions
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 17: | Line 17: | ||
==Cancer Category/Type== | ==Cancer Category/Type== | ||
*[[Mature B-Cell Neoplasms]] | *[[HAEM4:Mature B-Cell Neoplasms]] | ||
==Cancer Sub-Classification / Subtype== | ==Cancer Sub-Classification / Subtype== | ||
| Line 162: | Line 162: | ||
Some cases of gamma-HCD (γ-HCD) are concurrent with other lymphoid neoplasm have been reported in the literature and are listed below; treatment option varies with concurrent neoplasm | Some cases of gamma-HCD (γ-HCD) are concurrent with other lymphoid neoplasm have been reported in the literature and are listed below; treatment option varies with concurrent neoplasm | ||
*[[Chronic | *[[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)]] | ||
*DLBCL-diffuse large B cell Lymphoma | *DLBCL-diffuse large B cell Lymphoma | ||
*LCPD-lymphoplasma cell proliferative disorder | *LCPD-lymphoplasma cell proliferative disorder | ||
*[[Lymphoplasmacytic | *[[HAEM5:Lymphoplasmacytic lymphoma|Lymphoplasmacytic Lymphoma (LPL]]) | ||
*MALT -mucosa-associated lymphoid tissue | *MALT -mucosa-associated lymphoid tissue | ||
*MDS-myelodysplastic syndrome | *MDS-myelodysplastic syndrome | ||